Ocera Initiates Phas
Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis
June 01, 2017 09:05 ET | Ocera Therapeutics, Inc.
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., June 01, 2017 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), today announced the dosing of the first patients in Part Two of a...
logo_ProQR-150x150.png
ProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10
May 31, 2017 07:00 ET | ProQR Therapeutics N.V.
 Key Updates ProQR receives Fast Track designation by the U.S. Food and Drug Administration (FDA). Closer interaction with FDA could potentially accelerate the development of QR-110 in patients...
Dr. Bristow
ARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business Update
May 15, 2017 08:30 ET | ARCA Biopharma, Inc.
WESTMINSTER, Colo., May 15, 2017 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
US FDA pathway opens to SCENESSE® following Fast Track designation for treatment of EPP
July 06, 2016 08:00 ET | Clinuvel Pharmaceuticals Limited
FDA awards Fast Track Designation¹ to expedite review of SCENESSE® in EPPNDA filing allowed on a rolling basisFDA hosting a Scientific Workshop² on EPP to learn more about disease and drug treatment ...
LOGO JPG.jpg
FDA Grants Fast Track Designation to Cempra for Solithromycin in the Treatment of Community Acquired Bacterial Pneumonia
August 19, 2015 07:00 ET | Melinta Therapeutics, Inc.
CHAPEL HILL, N.C., Aug. 19, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
FDA Grants Fast Trac
FDA Grants Fast Track Designation to Sucampo's Cobiprostone for Oral Mucositis
May 07, 2015 16:42 ET | Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 7, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA)...
New Mondo Logo
Three world records set on new Mondo Super X 720 surface at IAAF World Relays
May 27, 2014 14:03 ET | Mondo
NASSAU, Bahamas, May 27, 2014 (GLOBE NEWSWIRE) -- Once again, Mondo is the surface of new world records. At the inaugural International Association of Athletics Federation's (IAAF) World Relays last...
New Mondo Logo
Inaugural IAAF World Relays to be held on new Mondo Super X 720 surface
May 22, 2014 07:10 ET | Mondo
NASSAU, Bahamas, May 22, 2014 (GLOBE NEWSWIRE) -- When the 500-plus athletes from more than 40 different countries take their marks on the track during this weekend's highly anticipated inaugural...
Atidan, LLC logo
Atidan Offers Microsoft Office 365 Deployment Funding
January 28, 2014 11:28 ET | Atidan, LLC
Yardley, PA, Jan. 28, 2014 (GLOBE NEWSWIRE) -- (http://www.myprgenie.com) -- Atidan is pleased to offer funding for organizations who deploy a minimum of 150 seats of Microsoft Office 365 purchased...
Nuvilex Eyes FDA Fas
Nuvilex Eyes FDA Fast Track After ABRAXANE Approved for Pancreatic Cancer
September 11, 2013 08:45 ET | Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Sep 11, 2013) - Nuvilex, Inc. (OTCQB: NVLX) and its shareholders enjoyed what could be a dress rehearsal of their own future with the Food and Drug Administration's...